Home  >  News  >  How to save your pharma R&D projects?
How to save your pharma R&D projects?

How to save your pharma R&D projects?

Supplier: European Business Conferences Group (EBCG) 08/01/2014

Description

The pharmaceutical industry is in great danger with the productivity of research and development rapidly decreasing as well as many major drug patents expiring in the upcoming years. It is high time to take action and receive valuable strategic and operational insights into the latest trends in the industry. At the Pharma PPM Toolbox 2014, which will take place in Zürich, Switzerland from the 19th - 21st March 2014, you will find out the answers also to these important questions:

•    What are the sources of innovation?
•    What are the best practices on post-patent management of brands?
•    How can you spot a project error before it turns into a disaster?

... and many, many more.

The biggest issue at hand is that the vast majority of R&D projects are unsuccesful – a staggering 68%. To make matters worse, 24%  - almost 1 in 4 projects - are considered absolute failures. Increasing success rates is equivalent to increasing R&D productivity which is required to reduce the high costs of succesfully developing a new drug (on average over $5 billion US dollars).

This year's conference will be the 4th annual event held by EBCG on the topic of Pharma PPM. You will learn the most effective tips and tricks from industry-leading experts. This is an event that you should not miss if you want to make your pharma pipelines more successful in upcoming years.

'' One of the best conferences I have ever attended – very interesting and stimulating presentations, and -discussions, and excellent networking opportunities as well.'' says one of our past attendees, Head of R&D Project Managment at Boehringer Ingelheim. To learn more, please click here.
Button_on Button_off_labsave Button_off_labsave Button_off_labsave